Enlivex (ENLV) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.20, -8.48% vs the prior close of $0.22.
- Volume 452.88K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ENLV slides 8.5% to $0.20, a 52-week low. Closed at $0.20, -8.48% vs the prior close of $0.22. Day range $0.20–$0.23, opened at $0.23.
ENLV daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ENLV slides 8.5% to $0.20, a 52-week low
- Closed at $0.20, -8.48% vs the prior close of $0.22. Day range $0.20–$0.23, opened at $0.23.
- Volume was 452.88K shares, 0.4x its 50-day average of 1.18M — lighter than usual.
- Price is -78.9% vs its 50-day average ($0.97) and -97.8% vs its 200-day average ($9.33).
- 52-week range $0.20–$27.15; today's close sits at 0% of that range, 99.2% below the 52-week high.
Oct 15, 2026 — ENLV jumps 3.7% to $0.22
- Closed at $0.22, +3.70% vs the prior close of $0.22. Day range $0.21–$0.24, opened at $0.22.
- Volume was 557.80K shares, 0.5x its 50-day average of 1.18M — lighter than usual.
- Price is -77.8% vs its 50-day average ($1.01) and -97.6% vs its 200-day average ($9.38).
- 52-week range $0.21–$27.15; today's close sits at 0% of that range, 99.2% below the 52-week high.
Oct 14, 2026 — ENLV dips 2.7% to $0.22, a 52-week low, 10 down days in a row
- Closed at $0.22, -2.70% vs the prior close of $0.22. Day range $0.21–$0.23, opened at $0.22.
- Volume was 556.80K shares, 0.5x its 50-day average of 1.18M — lighter than usual.
- Price is -79.4% vs its 50-day average ($1.05) and -97.7% vs its 200-day average ($9.44).
- 52-week range $0.21–$27.15; today's close sits at 0% of that range, 99.2% below the 52-week high.
- That makes 10 straight losses.
Oct 13, 2026 — ENLV slides 12.3% to $0.22, a 52-week low, 9 down days in a row
- Closed at $0.22, -12.25% vs the prior close of $0.25. Day range $0.22–$0.26, opened at $0.26.
- Volume was 868.40K shares, 0.7x its 50-day average of 1.16M.
- Price is -79.6% vs its 50-day average ($1.09) and -97.7% vs its 200-day average ($9.49).
- 52-week range $0.22–$27.15; today's close sits at 0% of that range, 99.2% below the 52-week high.
- That makes 9 straight losses.
Oct 12, 2026 — ENLV dips 0.4% to $0.25, a 52-week low, 8 down days in a row
- Closed at $0.25, -0.39% vs the prior close of $0.25. Day range $0.25–$0.26, opened at $0.26.
- Volume was 892.90K shares, 0.8x its 50-day average of 1.15M.
- Price is -77.5% vs its 50-day average ($1.13) and -97.3% vs its 200-day average ($9.55).
- 52-week range $0.22–$27.15; today's close sits at 0% of that range, 99.1% below the 52-week high.
- That makes 8 straight losses.
Oct 9, 2026 — ENLV slides 8.3% to $0.25, a 52-week low on 2.5x normal volume
- Closed at $0.25, -8.30% vs the prior close of $0.28. Day range $0.22–$0.28, opened at $0.25.
- Volume was 2.78M shares, 2.5x its 50-day average of 1.10M — unusually heavy trading.
- Price is -78.1% vs its 50-day average ($1.16) and -97.4% vs its 200-day average ($9.61).
- 52-week range $0.22–$27.15; today's close sits at 0% of that range, 99.1% below the 52-week high.
- That makes 7 straight losses.
Oct 8, 2026 — ENLV slides 9.5% to $0.28, a 52-week low on 71.4x normal volume
- Closed at $0.28, -9.48% vs the prior close of $0.31. Day range $0.25–$0.43, opened at $0.33.
- Volume was 32.68M shares, 71.4x its 50-day average of 457.74K — unusually heavy trading.
- Price is -76.8% vs its 50-day average ($1.20) and -97.1% vs its 200-day average ($9.67).
- 52-week range $0.25–$27.15; today's close sits at 0% of that range, 99.0% below the 52-week high.
- That makes 6 straight losses.
Oct 7, 2026 — ENLV slides 10.0% to $0.31, a 52-week low on 8.5x normal volume
- Closed at $0.31, -10.00% vs the prior close of $0.34. Day range $0.30–$0.35, opened at $0.35.
- Volume was 3.90M shares, 8.5x its 50-day average of 460.55K — unusually heavy trading.
- Price is -75.2% vs its 50-day average ($1.24) and -96.9% vs its 200-day average ($9.73).
- 52-week range $0.30–$27.15; today's close sits at 0% of that range, 98.9% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — ENLV slides 6.1% to $0.34, a 52-week low, 4 down days in a row
- Closed at $0.34, -6.08% vs the prior close of $0.36. Day range $0.34–$0.38, opened at $0.37.
- Volume was 409.30K shares, 0.9x its 50-day average of 453.55K.
- Price is -73.3% vs its 50-day average ($1.27) and -96.5% vs its 200-day average ($9.79).
- 52-week range $0.34–$27.15; today's close sits at 0% of that range, 98.7% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — ENLV slides 6.5% to $0.36, a 52-week low, 3 down days in a row
- Closed at $0.36, -6.46% vs the prior close of $0.39. Day range $0.36–$0.41, opened at $0.40.
- Volume was 423.20K shares, 0.9x its 50-day average of 447.22K.
- Price is -73.2% vs its 50-day average ($1.35) and -96.3% vs its 200-day average ($9.85).
- 52-week range $0.36–$27.15; today's close sits at 0% of that range, 98.7% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — ENLV slides 8.5% to $0.39, a 52-week low
- Closed at $0.39, -8.51% vs the prior close of $0.42. Day range $0.38–$0.43, opened at $0.42.
- Volume was 631.10K shares, 1.4x its 50-day average of 437.21K.
- Price is -72.9% vs its 50-day average ($1.43) and -96.1% vs its 200-day average ($9.91).
- 52-week range $0.38–$27.15; today's close sits at 0% of that range, 98.6% below the 52-week high.
ENLV latest news & SEC filings
Every SEC filing by or about ENLV in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 25, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 22, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 17, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 13, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 6, 2026 · Form F-3 — F-3 filing
F-3 filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 29, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 28, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 28, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 20, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade ENLV
- How much it moves: over the last 20 sessions the average daily move was 7.31% (largest 15.9%). That is a volatile stock.
- Liquidity: about 2.51M shares (≈$515.41K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.20 vs a range of $0.20–$27.15 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:15 on Jul 9, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Sep 29, 2026; 6-K Sep 25, 2026; 6-K Sep 22, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ENLV market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.23 | 0.23 | 0.20 | 0.20 | 452.88K |
| Oct 15, 2026 | 0.22 | 0.24 | 0.21 | 0.22 | 557.80K |
| Oct 14, 2026 | 0.22 | 0.23 | 0.21 | 0.22 | 556.80K |
| Oct 13, 2026 | 0.26 | 0.26 | 0.22 | 0.22 | 868.40K |
| Oct 12, 2026 | 0.26 | 0.26 | 0.25 | 0.25 | 892.90K |
| Oct 9, 2026 | 0.25 | 0.28 | 0.22 | 0.25 | 2.78M |
| Oct 8, 2026 | 0.33 | 0.43 | 0.25 | 0.28 | 32.68M |
| Oct 7, 2026 | 0.35 | 0.35 | 0.30 | 0.31 | 3.90M |
| Oct 6, 2026 | 0.37 | 0.38 | 0.34 | 0.34 | 409.30K |
| Oct 5, 2026 | 0.40 | 0.41 | 0.36 | 0.36 | 423.20K |
| Oct 2, 2026 | 0.42 | 0.43 | 0.38 | 0.39 | 631.10K |
| Oct 1, 2026 | 0.49 | 0.50 | 0.41 | 0.42 | 755.10K |
| Sep 30, 2026 | 0.48 | 0.58 | 0.47 | 0.50 | 968.70K |
| Sep 29, 2026 | 0.52 | 0.53 | 0.47 | 0.48 | 585.80K |
| Sep 28, 2026 | 0.60 | 0.60 | 0.50 | 0.51 | 631.00K |
| Sep 25, 2026 | 0.60 | 0.62 | 0.58 | 0.60 | 316.00K |
| Sep 24, 2026 | 0.63 | 0.64 | 0.57 | 0.61 | 377.00K |
| Sep 23, 2026 | 0.63 | 0.69 | 0.62 | 0.64 | 593.60K |
| Sep 22, 2026 | 0.69 | 0.71 | 0.57 | 0.65 | 1.23M |
| Sep 21, 2026 | 0.84 | 0.85 | 0.67 | 0.69 | 668.80K |
About Enlivex
Enlivex (ENLV) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in TEL AVIV. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 1596812.
ENLV board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Gili Hart | Director | Mar 18, 2026 |
| Avraham Havron | Director | Mar 18, 2026 |
| Shai A Novik | Director | Mar 18, 2026 |
| Roger Pomerantz | Director | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Einat Galamidi | Chief Medical Officer | Mar 18, 2026 |
| Oren Hershkovitz | Chief Executive Officer | Mar 18, 2026 |
| Shachar Shlosberger | Chief Financial Officer | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ENLV financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
ENLV earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ENLV
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.